Contact Us

Open Clinical Trials at Colorado Clinical Research

 

Invitae Study

A multi-center prospective observational study of community urology practices applying germline genetic testing for prostate cancer patients. Click here for more information.

Magnitude Study

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer. To learn more, watch the video here.

Proteus Study

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy.
Click here for more information.

Prevalence Study

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer. Call 303-996-9649 for more information.

Advantagene PrTK03 Study

A Randomized Controlled Trial of ProstaTak as Adjuvant to Up-Front Radiation Therapy for Localized Prostate Cancer. Click here for more information. 

 

We’re here to help- Call Colorado Clinical Research for more information about our open clinical trials – 303-996-9649. 

Contact Us

Appointments & Information

*If this is an emergency, please call 911 immediately.

Please provide your email address and phone number and a Colorado Urology representative will contact you shortly to assist with your question or issue.

Monday–Friday, 8:30 a.m. to 4:30 p.m.

  • This field is for validation purposes and should be left unchanged.

Contact Us